469 related articles for article (PubMed ID: 25687470)
1. Histone deacetylase 6 in health and disease.
Seidel C; Schnekenburger M; Dicato M; Diederich M
Epigenomics; 2015; 7(1):103-18. PubMed ID: 25687470
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the discovery of potent and selective HDAC6 inhibitors.
Wang XX; Wan RZ; Liu ZP
Eur J Med Chem; 2018 Jan; 143():1406-1418. PubMed ID: 29133060
[TBL] [Abstract][Full Text] [Related]
3. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
Li G; Jiang H; Chang M; Xie H; Hu L
J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
[TBL] [Abstract][Full Text] [Related]
4. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer.
Seidel C; Schnekenburger M; Mazumder A; Teiten MH; Kirsch G; Dicato M; Diederich M
Biochem Pharmacol; 2016 Jan; 99():31-52. PubMed ID: 26549368
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes.
Li Y; Shin D; Kwon SH
FEBS J; 2013 Feb; 280(3):775-93. PubMed ID: 23181831
[TBL] [Abstract][Full Text] [Related]
6. A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity.
Zhang XH; Qin-Ma ; Wu HP; Khamis MY; Li YH; Ma LY; Liu HM
J Med Chem; 2021 Feb; 64(3):1362-1391. PubMed ID: 33523672
[TBL] [Abstract][Full Text] [Related]
7. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Expression and Functions of Histone Deacetylase 6 (HDAC6).
Li M; Zhuang Y; Shan B
Methods Mol Biol; 2016; 1436():85-94. PubMed ID: 27246209
[TBL] [Abstract][Full Text] [Related]
9. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
Han Y; Jeong HM; Jin YH; Kim YJ; Jeong HG; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2009 May; 383(1):88-92. PubMed ID: 19344692
[TBL] [Abstract][Full Text] [Related]
10. [Histone deacetylase 6: structure, functions and development of selective inhibitors].
Liu RS; Fang H
Yao Xue Xue Bao; 2015 Jan; 50(1):7-14. PubMed ID: 25924468
[TBL] [Abstract][Full Text] [Related]
11. Development and therapeutic implications of selective histone deacetylase 6 inhibitors.
Kalin JH; Bergman JA
J Med Chem; 2013 Aug; 56(16):6297-313. PubMed ID: 23627282
[TBL] [Abstract][Full Text] [Related]
12. Aceroside VIII is a new natural selective HDAC6 inhibitor that synergistically enhances the anticancer activity of HDAC inhibitor in HT29 cells.
Ryu HW; Lee DH; Shin DH; Kim SH; Kwon SH
Planta Med; 2015 Feb; 81(3):222-7. PubMed ID: 25590368
[TBL] [Abstract][Full Text] [Related]
13. Structure, Functions and Selective Inhibitors of HDAC6.
Liang T; Fang H
Curr Top Med Chem; 2018; 18(28):2429-2447. PubMed ID: 30499393
[TBL] [Abstract][Full Text] [Related]
14. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
15. A novel class of anthraquinone-based HDAC6 inhibitors.
Song Y; Lim J; Seo YH
Eur J Med Chem; 2019 Feb; 164():263-272. PubMed ID: 30597327
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease.
Batchu SN; Brijmohan AS; Advani A
Clin Sci (Lond); 2016 Jun; 130(12):987-1003. PubMed ID: 27154743
[TBL] [Abstract][Full Text] [Related]
17. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.
Zhang Y; Kwon S; Yamaguchi T; Cubizolles F; Rousseaux S; Kneissel M; Cao C; Li N; Cheng HL; Chua K; Lombard D; Mizeracki A; Matthias G; Alt FW; Khochbin S; Matthias P
Mol Cell Biol; 2008 Mar; 28(5):1688-701. PubMed ID: 18180281
[TBL] [Abstract][Full Text] [Related]
18. The histone deacetylase-6 inhibitor tubacin directly inhibits de novo sphingolipid biosynthesis as an off-target effect.
Siow D; Wattenberg B
Biochem Biophys Res Commun; 2014 Jul; 449(3):268-71. PubMed ID: 24835950
[TBL] [Abstract][Full Text] [Related]
19. HDAC6-Dependent Functions in Tumor Cells: Crossroad with the MAPK Pathways.
Haakenson J; Wu JY; Xiang S; Williams KA; Bai W; Zhang X
Crit Rev Oncog; 2015; 20(1-2):65-81. PubMed ID: 25746105
[TBL] [Abstract][Full Text] [Related]
20. Cystathionine γ-lyase protects vascular endothelium: a role for inhibition of histone deacetylase 6.
Leucker TM; Nomura Y; Kim JH; Bhatta A; Wang V; Wecker A; Jandu S; Santhanam L; Berkowitz D; Romer L; Pandey D
Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H711-H720. PubMed ID: 28188215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
